Apolipoprotein synthesis and secretion in Hep G2 cells: effects of monensin and cycloheximide.
Hep G2 cells were used to study the relationship between apolipoprotein synthesis and secretion, as revealed by their interaction with agents modulating these processes. Cycloheximide inhibited the secretion of both apolipoproteins (apo) AI and B, but the reduction in apo AI secretion was evident at earlier times. Monensin also inhibited secretion of apo AI and apo B, but only apo AI accumulated intracellularly. Pulse-chase studies showed that, at concentrations of monensin that had no effect on total protein synthesis, apo B synthesis was specifically inhibited. Triacylglycerol synthesis was inhibited to the same extent as apo B synthesis, but this preceded the latter inhibition and unlike apo B there was an accumulation of intracellular triglyceride. These results suggest that distinctive mechanisms modulate the synthesis and secretion of apo AI and apo B, and that apo B synthesis can be specifically inhibited by mechanisms that initially block triglyceride production.
Hahn
S E
SE
Department of Clinical Biochemistry, University of Toronto, Banting Institute, Ont., Canada.
Parkes
J G
JG
Goldberg
D M
DM
D016632:Apolipoprotein A-I / Q000096:biosynthesis / Q000378:metabolism; D001053:Apolipoproteins / Q000096:biosynthesis* / Q000378:metabolism; D001055:Apolipoproteins B / Q000096:biosynthesis / Q000378:metabolism; D006528:Carcinoma, Hepatocellular; D003513:Cycloheximide / Q000494:pharmacology*; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008113:Liver Neoplasms; D008985:Monensin / Q000494:pharmacology*; D014280:Triglycerides / Q000096:biosynthesis; D014407:Tumor Cells, Cultured
D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D001055:Apolipoproteins B; D008074:Lipoproteins; D014280:Triglycerides; D008985:Monensin; D003513:Cycloheximide